Open AccessPerformance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
Author(s) -
Yong Qian,
Junming Guo,
Yansong Chen,
Zhaolei Cui,
Yan Chen
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s320541
Subject(s) - nasopharyngeal carcinoma , antibody , titer , immunology , viral load , virus , medicine , epstein–barr virus , virology , radiation therapy
The aim of this study was to evaluate the effectiveness of Epstein-Barr virus (EBV) VCA-IgA antibody, EBV DNA and HSP90α alone or in combinations for the diagnosis and prognostic prediction of nasopharyngeal carcinoma (NPC).